This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Effectiveness of Olanzapine for Systemic Lupus Erythematosus-Related Psychosis

Joel P. Pinto, MD; Silvio Luiz Morais, MD; Jaime E. C. Hallak, MD; Serdar M. Dursan, MD

Published: December 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We report a case of olanzapine treatment of psychotic symptoms related to systemic lupus erythematosus (SLE). There is evidence that SLE can affect the central nervous system, among other parts of the body. Reports of psychotic presentation in SLE are rare, but such presentations are often dramatic, causing impairment in quality of life and difficulties for treatment.1,2 To our knowledge, there are no reports of effectiveness of olanzapine, an atypical antipsychotic, for SLE-related psychosis.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 8

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...